Insys Therapeutics, Inc. Gross Margin 2013-2019 | INSYQ
Current and historical gross margin for Insys Therapeutics, Inc. (INSYQ) over the last 10 years. The current gross profit margin for Insys Therapeutics, Inc. as of March 31, 2019 is %.
Gross Margin Historical Data |
Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
2019-03-31 |
$0.07B |
$0.05B |
81.54% |
2018-12-31 |
$0.08B |
$0.07B |
88.89% |
2018-09-30 |
$0.10B |
$0.09B |
88.54% |
2018-06-30 |
$0.11B |
$0.09B |
84.40% |
2018-03-31 |
$0.13B |
$0.11B |
86.05% |
2017-12-31 |
$0.14B |
$0.12B |
85.11% |
2017-09-30 |
$0.17B |
$0.14B |
83.64% |
2017-06-30 |
$0.19B |
$0.17B |
87.50% |
2017-03-31 |
$0.22B |
$0.19B |
88.07% |
2016-12-31 |
$0.24B |
$0.22B |
89.67% |
2016-09-30 |
$0.28B |
$0.26B |
92.17% |
2016-06-30 |
$0.31B |
$0.29B |
91.99% |
2016-03-31 |
$0.32B |
$0.30B |
91.64% |
2015-12-31 |
$0.33B |
$0.30B |
90.94% |
2015-09-30 |
$0.30B |
$0.27B |
90.67% |
2015-06-30 |
$0.27B |
$0.24B |
90.71% |
2015-03-31 |
$0.25B |
$0.22B |
90.20% |
2014-12-31 |
$0.22B |
$0.20B |
89.95% |
2014-09-30 |
$0.20B |
$0.17B |
88.78% |
2014-06-30 |
$0.17B |
$0.15B |
88.02% |
2014-03-31 |
$0.13B |
$0.11B |
87.69% |
2013-12-31 |
$0.10B |
$0.09B |
86.87% |
2013-09-30 |
$0.06B |
$0.05B |
84.38% |
2013-06-30 |
$0.04B |
$0.03B |
77.50% |
2013-03-31 |
$0.03B |
$0.02B |
64.00% |
2012-12-31 |
$0.02B |
$0.01B |
50.00% |